Using Boarding Ring Glasses to Treat Vestibular Neuritis
Evaluation of the Efficacy of BOARDING RING Glasses in the Treatment of Vestibular Neuritis
This study tests if wearing Boarding Ring glasses can help people with vestibular neuritis recover from vertigo faster than those who don’t wear the glasses.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 51 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 2 sites (Brest and 1 other locations) |
| Trial ID | NCT04678167 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of Boarding Ring glasses in accelerating vestibular compensation for patients suffering from vestibular neuritis, a condition characterized by intense and prolonged vertigo. Participants will undergo various assessments, including caloric tests and measurements of nystagmus, to determine the impact of the glasses compared to placebo or no glasses. The study aims to provide insights into a potential non-invasive treatment option for this debilitating condition.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with vestibular neuritis who experience continuous rotating vertigo and have specific clinical signs such as spontaneous nystagmus.
Not a fit: Patients with a history of vestibular vertigo lasting more than four days, associated hearing loss, or central ocular abnormalities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a new, effective treatment option for patients suffering from vestibular neuritis, potentially reducing their symptoms and improving their quality of life.
How similar studies have performed: While this approach is relatively novel, similar studies exploring non-invasive interventions for vestibular disorders have shown promise, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult patients, * patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea * patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear * patient with a postural deviation towards the affected ear; * vestibular hyporeflexia measured at the caloric tests greater than 25% * patient who has given free, enlighten and written consent Exclusion Criteria: * patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days * patient with associated hearing loss or tinnitus * patient with an motor ocular abnormality of central origin * patient refusal or inability to consent
Where this trial is running
Brest and 1 other locations
- CHU de Brest — Brest, France (Recruiting)
- CH Pays de Morlaix — Morlaix, France (Terminated)
Study contacts
- Principal investigator: Jean-Christophe LECLERE, Dr — University Hospital, Brest
- Study coordinator: Jean-Christophe LECLERE, Dr
- Email: jean-christophe.leclere@chu-brest.fr
- Phone: 02.98.22.33.78
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.